Intraventricular Brain Hemorrhage clinical trials
13 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage
- Intraventricular Catheter System for IVH
- International Care Bundle Evaluation in Cerebral Hemorrhage Research
- AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
- A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
- Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates
- Improving Outcomes for Patients With Life-Threatening Neurologic Illness
- Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- Ventricular mTOR Inhibition to Prevent Hydrocephalus After Brain Hemorrhage
- Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization
- Single-dose Prophylactic INdomethacin in Extremely Preterm Infants
- CleaRRAflow: Isotonic Solution vs. TPA for IVH Clearance
- Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Intraventricular Brain Hemorrhage” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.